ARCHIVES

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

This article is from The Cancer Letter archive.

Vol. 40 No. 38 | October 10, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

UPCI Puts the Cancer Letter on its Intranet for Employees

May 5, 2000

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013